HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charalampos Tzoulis Selected Research

nicotinamide-beta-riboside

1/2024The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC derived Cortical Organoid of Alpers' Disease.
11/2023NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease.
3/2023Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease.
1/2022The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
1/2020Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charalampos Tzoulis Research Topics

Disease

23Parkinson Disease (Parkinson's Disease)
04/2024 - 11/2012
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 11/2016
5Dementia (Dementias)
01/2022 - 01/2018
5Brain Diseases (Brain Disorder)
01/2021 - 05/2010
4Mitochondrial Diseases (Mitochondrial Disease)
01/2024 - 08/2013
3Cognitive Dysfunction
01/2022 - 08/2015
3Epilepsy (Aura)
11/2017 - 12/2012
3Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2017 - 05/2010
2Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
01/2020 - 05/2010
2Muscular Diseases (Myopathy)
01/2019 - 06/2010
2Parkinsonian Disorders (Parkinsonism)
01/2018 - 04/2016
2Stroke (Strokes)
01/2017 - 02/2009
2Neoplasms (Cancer)
01/2017 - 04/2015
2Spastic Paraparesis
04/2015 - 08/2008
2Spastic Paraplegia Type 7
01/2014 - 08/2008
2Status Epilepticus (Complex Partial Status Epilepticus)
03/2008 - 07/2006
2Liver Failure
03/2008 - 07/2006
1Tremor (Tremors)
04/2024
1Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease)
01/2024
1Malnutrition (Nutritional Deficiencies)
12/2023
1Chronic Disease (Chronic Diseases)
12/2023
1Neural Tube Defects (Exencephaly)
12/2023
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Neurobehavioral Manifestations
11/2021
1Blepharospasm
01/2021
1Genomic Instability
01/2021
1Torticollis (Wryneck)
01/2021
1Gliosis
01/2020
1Sepsis (Septicemia)
01/2020
1Fatigue
01/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020
1Sporadic Creutzfeldt-Jakob Disease
01/2020
1Inclusion Body Myositis
01/2019
1Leigh Disease (Leigh's Disease)
01/2018
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2018
1Ophthalmoplegia (External Ophthalmoplegia)
01/2018
1Ataxia (Dyssynergia)
01/2018
1Cardiomyopathies (Cardiomyopathy)
01/2018
1Synucleinopathies
12/2017
1Neuroblastoma
12/2017
1Hypoxia (Hypoxemia)
01/2017
1Multiple Sclerosis
01/2017
1Relapsing-Remitting Multiple Sclerosis
01/2017
1Premature Aging
11/2016
1Basal Ganglia Diseases (Basal Ganglia Disease)
01/2016
1Erdheim-Chester Disease
04/2015
1Failure to Thrive
04/2014

Drug/Important Bio-Agent (IBA)

17Mitochondrial DNA (mtDNA)IBA
04/2024 - 02/2009
6NAD (NADH)IBA
01/2024 - 01/2020
5nicotinamide-beta-ribosideIBA
01/2024 - 01/2020
5Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2013
4SynucleinsIBA
01/2022 - 12/2017
3Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2018
3DNA Polymerase gammaIBA
12/2012 - 05/2010
2Glucosylceramidase (Glucocerebrosidase)IBA
01/2022 - 10/2018
2Apolipoproteins E (ApoE)IBA
01/2022 - 11/2021
2Adenosine Triphosphate (ATP)IBA
01/2020 - 08/2008
2Lactic Acid (Lactate)FDA LinkGeneric
01/2017 - 02/2012
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2016 - 08/2013
2Aspartate-tRNA LigaseIBA
01/2016 - 02/2012
2Valproic Acid (Depakote)FDA LinkGeneric
03/2008 - 07/2006
1MicronutrientsIBA
12/2023
1Choline (Choline Chloride)IBA
12/2023
1XanthophyllsIBA
12/2023
1Neuroprotective AgentsIBA
03/2023
1ProteomeIBA
02/2023
1ChromatinIBA
01/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022
1ApolipoproteinsIBA
01/2022
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2021
1DNA Glycosylases (DNA Glycosylase)IBA
01/2021
1Histones (Histone)IBA
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1Botulinum Toxins (Botulinum Toxin)IBA
01/2021
1Type A Botulinum Toxins (Botox)FDA Link
01/2021
1incobotulinumtoxinAFDA Link
01/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1Prion ProteinsIBA
01/2020
1LipidsIBA
01/2020
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2018
1Protein AggregatesIBA
12/2017
1alpha-SynucleinIBA
12/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2017
1ElementsIBA
11/2017
1UbiquitinIBA
01/2017
1Lactate Dehydrogenase 5IBA
01/2017
1EnzymesIBA
01/2017
1Simvastatin (Zocor)FDA LinkGeneric
01/2017
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2017
1Biotin (Vitamin H)FDA Link
01/2016
1Thiamine (Aneurin)FDA Link
01/2016
1Ferritins (Ferritin)IBA
08/2015
1VemurafenibIBA
04/2015

Therapy/Procedure

4Therapeutics
12/2023 - 04/2015
2Denervation
01/2018 - 04/2016
1Institutionalization (Institutionalized Persons)
06/2020
1Critical Care (Surgical Intensive Care)
04/2014